Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Obstructive Lung Diseases

Free Subscription 09.03.2026 4 Ann Allergy Asthma Immunol 2 Eur Respir J 1 Pediatr Pulmonol 1 PLoS One 7 Respir Med 1 Respir Res 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Allergy Asthma Immunol

1. CHEN R, Talapatra K, Ali S, Lyu J, et al
   Effect of background asthma and allergic conditions on prophylaxis and treatment of COVID-19 infection.
   Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00070.
   PubMed         Abstract available
   
   
2. COYLE L, McDowell PJ, Heaney LG
   Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
   Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00069.
   PubMed         Abstract available
   
   
3. KHARBANDA S, Stocker L, Rupani H
   Asthma in pregnancy: optimising treatment strategies and the emerging role of biologic therapies.
   Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00071.
   PubMed         Abstract available
   
   
4. BOZEK A, Urbaniec E, Miodonska M, Scierski W, et al
   Efficacy of Omalizumab in Moderate Chronic Rhinosinusitis With Nasal Polyps and Immunoglobulin E-Mediated Asthma.
   Ann Allergy Asthma Immunol. 2026 Feb 27:S1081-1206(26)00073.
   PubMed         Abstract available
   
   

   
   Eur Respir J

5. SORIANO JB, Perez de Llano LA
   Severe asthma: an indirect, subtle killer.
   Eur Respir J. 2026;67:2502402.
   PubMed        
   
   
6. AUCOIN R, Nguyen D, Ross B, Bourbeau J, et al
   Facial airflow enhances the benefits of exercise training in people with chronic lung disease: a randomised controlled trial.
   Eur Respir J. 2026;67:2501109.
   PubMed         Abstract available
   
   

   
   Pediatr Pulmonol

7. GERGO D, Garmaa G, Harsfalvi P, Wenning AS, et al
   Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients (EXOTIC): Protocol of a Randomized, Double-Blind Clinical Trial.
   Pediatr Pulmonol. 2026;61:e71544.
   PubMed         Abstract available
   
   

   
   PLoS One

8. ZHOU Y, Gong H, Hao Z, Wang L, et al
   Based on single-cell and transcriptome analysis of inflammatory pathway biomarkers and their molecular mechanisms in chronic obstructive pulmonary disease.
   PLoS One. 2026;21:e0343798.
   PubMed         Abstract available
   
   

   
   Respir Med

9. DE S
   Respiratory reactance index across severities of airflow obstruction in COPD and asthma.
   Respir Med. 2026;254:108752.
   PubMed        
   
   
10. HALASEH RM, Al-Ahmad M, Boppana LKT, Al-Tarbsheh A, et al
    Bronchiectasis: Past insights, present clinical evidence, and future research pathways.
    Respir Med. 2026;254:108744.
    PubMed         Abstract available
    
    
11. LIN L, Zhu F, Xiao J, Yang L, et al
    The minimal clinically important difference of patient-reported outcome measures in adults with asthma: a systematic review.
    Respir Med. 2026 Mar 1:108747. doi: 10.1016/j.rmed.2026.108747.
    PubMed         Abstract available
    
    
12. KANABAR SS, Pavord ID, Hinks TSC
    Treatable traits and treatment options in asthma.
    Respir Med. 2026 Feb 26:108736. doi: 10.1016/j.rmed.2026.108736.
    PubMed         Abstract available
    
    
13. VIJAY S, Sehgal IS, Agarwal R, Muthu V, et al
    Adaptive support ventilation with IntelliSync versus pressure support ventilation for non-invasive ventilation in acute exacerbation of COPD: A feasibility randomized trial.
    Respir Med. 2026;253:108690.
    PubMed         Abstract available
    
    
14. ZANELI S, Bakakos A, Bartziokas K, Papaporfyriou A, et al
    Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation.
    Respir Med. 2026;253:108681.
    PubMed         Abstract available
    
    
15. LOMMATZSCH M, Schmidt O, Timmermann H, Gappa M, et al
    Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study.
    Respir Med. 2026 Mar 3:108750. doi: 10.1016/j.rmed.2026.108750.
    PubMed         Abstract available
    
    

    
    Respir Res

16. TUMMLER B, Schulz A, Minso R, Alfeis N, et al
    CFTR activity in nasal potential difference of adults with idiopathic bronchiectasis.
    Respir Res. 2026 Mar 3. doi: 10.1186/s12931-026-03599.
    PubMed        
    
    

    
    Thorax

17. SHAH PA, Diver S, Brightling CE
    Global asthma and pest control: bugs and WASPs.
    Thorax. 2026 Mar 3:thorax-2026-224743. doi: 10.1136/thorax-2026-224743.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum